Sichuan Dowell Science and Technology Inc.

SZSE:300535 Voorraadrapport

Marktkapitalisatie: CN¥1.5b

Sichuan Dowell Science and Technology Inkomsten in het verleden

Verleden criteriumcontroles 3/6

Sichuan Dowell Science and Technology's earnings have been declining at an average annual rate of -14.4%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 13% per year. Sichuan Dowell Science and Technology's return on equity is 0.02%, and it has net margins of 3.4%.

Belangrijke informatie

-14.4%

Groei van de winst

-14.9%

Groei van de winst per aandeel

Chemicals Groei van de industrie12.1%
Inkomstengroei13.0%
Rendement op eigen vermogen0.02%
Nettomarge3.4%
Laatste winstupdate30 Sep 2024

Recente prestatie-updates uit het verleden

We Think Sichuan Dowell Science and Technology's (SZSE:300535) Profit Is Only A Baseline For What They Can Achieve

May 01
We Think Sichuan Dowell Science and Technology's (SZSE:300535) Profit Is Only A Baseline For What They Can Achieve

Recent updates

Returns On Capital At Sichuan Dowell Science and Technology (SZSE:300535) Have Hit The Brakes

Jun 06
Returns On Capital At Sichuan Dowell Science and Technology (SZSE:300535) Have Hit The Brakes

We Think Sichuan Dowell Science and Technology's (SZSE:300535) Profit Is Only A Baseline For What They Can Achieve

May 01
We Think Sichuan Dowell Science and Technology's (SZSE:300535) Profit Is Only A Baseline For What They Can Achieve

What Sichuan Dowell Science and Technology Inc.'s (SZSE:300535) 36% Share Price Gain Is Not Telling You

Mar 08
What Sichuan Dowell Science and Technology Inc.'s (SZSE:300535) 36% Share Price Gain Is Not Telling You

Returns On Capital Signal Tricky Times Ahead For Sichuan Dowell Science and Technology (SZSE:300535)

Feb 26
Returns On Capital Signal Tricky Times Ahead For Sichuan Dowell Science and Technology (SZSE:300535)

Opbrengsten en kosten

Hoe Sichuan Dowell Science and Technology geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

SZSE:300535 Opbrengsten, kosten en inkomsten (CNY Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Sep 247472514448
30 Jun 247744413445
31 Mar 247673313347
31 Dec 237252812542
30 Sep 236472111237
30 Jun 23569611131
31 Mar 23520-310429
01 Jan 23510-210330
30 Sep 225301810539
30 Jun 225804010740
31 Mar 226196111040
01 Jan 226306611342
30 Sep 21655809344
30 Jun 21625869144
31 Mar 21542748542
31 Dec 20470578537
30 Sep 204224510636
30 Jun 203752410738
31 Mar 203722410739
31 Dec 193963910539
30 Sep 193543510931
30 Jun 193554010327
31 Mar 193614210625
31 Dec 183564110224
30 Sep 18364459025
30 Jun 18349468032
31 Mar 18334468225
31 Dec 17333528320
30 Sep 17335618114
30 Jun 1731759920
31 Mar 1731261850
31 Dec 1629958830
30 Sep 1628857780
30 Jun 1628254760
31 Mar 1627049730
31 Dec 1527548720
31 Dec 1427040740
31 Dec 1326734640

Kwaliteitswinsten: 300535 has a large one-off loss of CN¥32.0M impacting its last 12 months of financial results to 30th September, 2024.

Groeiende winstmarge: 300535's current net profit margins (3.4%) are higher than last year (3.3%).


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: 300535's earnings have declined by 14.4% per year over the past 5 years.

Versnelling van de groei: 300535's earnings growth over the past year (17.8%) exceeds its 5-year average (-14.4% per year).

Winst versus industrie: 300535 earnings growth over the past year (17.8%) exceeded the Chemicals industry -3.8%.


Rendement op eigen vermogen

Hoge ROE: 300535's Return on Equity (0.02%) is considered low.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden